Edward Zhang
Co-Founder & Chief Executive Officer Overland Therapeutics
Seminars
Thursday 17th September 2026
Highlighting Overland Therapeutics’ GPRC5D/BCMA Dual CAR-T Clinical Data
4:30 pm
